These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22835607)

  • 21. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats.
    Wang Q; Zuo XR; Wang YY; Xie WP; Wang H; Zhang M
    Vascul Pharmacol; 2013 Jan; 58(1-2):71-7. PubMed ID: 22846229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth.
    Ameshima S; Golpon H; Cool CD; Chan D; Vandivier RW; Gardai SJ; Wick M; Nemenoff RA; Geraci MW; Voelkel NF
    Circ Res; 2003 May; 92(10):1162-9. PubMed ID: 12714563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans.
    Bogaard HJ; Mizuno S; Guignabert C; Al Hussaini AA; Farkas D; Ruiter G; Kraskauskas D; Fadel E; Allegood JC; Humbert M; Vonk Noordegraaf A; Spiegel S; Farkas L; Voelkel NF
    Am J Respir Cell Mol Biol; 2012 May; 46(5):582-91. PubMed ID: 22162909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension.
    Al-Husseini A; Kraskauskas D; Mezzaroma E; Nordio A; Farkas D; Drake JI; Abbate A; Felty Q; Voelkel NF
    Pulm Circ; 2015 Mar; 5(1):101-16. PubMed ID: 25992275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.
    Happé CM; de Raaf MA; Rol N; Schalij I; Vonk-Noordegraaf A; Westerhof N; Voelkel NF; de Man FS; Bogaard HJ
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1088-97. PubMed ID: 27036867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt7a deficit is associated with dysfunctional angiogenesis in pulmonary arterial hypertension.
    Chakraborty A; Nathan A; Orcholski M; Agarwal S; Shamskhou EA; Auer N; Mitra A; Guardado ES; Swaminathan G; Condon DF; Yu J; McCarra M; Juul NH; Mallory A; Guzman-Hernandez RA; Yuan K; Rojas V; Crossno JT; Yung LM; Yu PB; Spencer T; Winn RA; Frump A; Karoor V; Lahm T; Hedlin H; Fineman JR; Lafyatis R; Knutsen CNF; Alvira CM; Cornfield DN; de Jesus Perez VA
    Eur Respir J; 2023 Jun; 61(6):. PubMed ID: 37024132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension.
    Abe K; Toba M; Alzoubi A; Ito M; Fagan KA; Cool CD; Voelkel NF; McMurtry IF; Oka M
    Circulation; 2010 Jun; 121(25):2747-54. PubMed ID: 20547927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary neovascularization of embryonic rat hearts cultured in oculo is independent of thyroid hormones.
    Rongish BJ; Torry RJ; Tomanek RJ
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H811-6. PubMed ID: 7532375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary arterial hypertension and thyroid disease.
    Silva DR; Gazzana MB; John AB; Siqueira DR; Maia AL; Barreto SS
    J Bras Pneumol; 2009 Feb; 35(2):179-85. PubMed ID: 19287922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe pulmonary hypertension: The role of metabolic and endocrine disorders.
    Bogaard HJ; Al Husseini A; Farkas L; Farkas D; Gomez-Arroyo J; Abbate A; Voelkel NF
    Pulm Circ; 2012; 2(2):148-54. PubMed ID: 22837855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CrossTalk proposal: The mouse SuHx model is a good model of pulmonary arterial hypertension.
    Penumatsa KC; Warburton RR; Hill NS; Fanburg BL
    J Physiol; 2019 Feb; 597(4):975-977. PubMed ID: 30499212
    [No Abstract]   [Full Text] [Related]  

  • 33. CrossTalk opposing view: The mouse SuHx model is not a good model of pulmonary arterial hypertension.
    Vitali SH
    J Physiol; 2019 Feb; 597(4):979-981. PubMed ID: 30499185
    [No Abstract]   [Full Text] [Related]  

  • 34. New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis.
    Nicolls MR; Mizuno S; Taraseviciene-Stewart L; Farkas L; Drake JI; Al Husseini A; Gomez-Arroyo JG; Voelkel NF; Bogaard HJ
    Pulm Circ; 2012 Oct; 2(4):434-42. PubMed ID: 23372927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional micro computed tomography analysis of the lung vasculature and differential adipose proteomics in the Sugen/hypoxia rat model of pulmonary arterial hypertension.
    Shields KJ; Verdelis K; Passineau MJ; Faight EM; Zourelias L; Wu C; Chong R; Benza RL
    Pulm Circ; 2016 Dec; 6(4):586-596. PubMed ID: 28090302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension.
    Philip N; Pi H; Gadkari M; Yun X; Huetsch J; Zhang C; Harlan R; Roux A; Graham D; Shimoda L; Le A; Visovatti S; Leary PJ; Gharib SA; Simpson C; Santhanam L; Steppan J; Suresh K
    Pulm Circ; 2023 Jan; 13(1):e12205. PubMed ID: 36873460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatoma-derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival.
    Yang J; Ambade AS; Nies M; Griffiths M; Damico R; Vaidya D; Brandal S; Pauciulo MW; Lutz KA; Coleman AW; Nichols WC; Austin ED; Ivy D; Hassoun PM; Everett AD
    Pulm Circ; 2022 Jan; 12(1):e12007. PubMed ID: 35506100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary hypertension in thyroid diseases.
    Scicchitano P; Dentamaro I; Tunzi F; Ricci G; Carbonara S; Devito F; Zito A; Ciampolillo A; Ciccone MM
    Endocrine; 2016 Dec; 54(3):578-587. PubMed ID: 26994930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid disease and primary pulmonary hypertension.
    Kashyap AS; Kashyap S
    JAMA; 2001 Jun; 285(22):2853-4. PubMed ID: 11401596
    [No Abstract]   [Full Text] [Related]  

  • 40. Thyroid disease in pulmonary hypertension: Strange bedfellows?
    Burger CD
    J Heart Lung Transplant; 2016 Dec; 35(12):1414-1415. PubMed ID: 27431752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.